Ensysce Biosciences announced it raised $77.2 Million in an initial filing from an offering of $77.2 Million
PUBLIC · ENSCAug 20, 2026
Amount Raised
$77.2 Million
Round Type
Venture
La JollaManufacturingBiotechnologyHealthcareHardwareFinancial ServicesFinanceFintechLendingBanking
Investors
Adage Capital PartnersIkarian CapitalDellora InvestmentsPerceptive AdvisorsAlly Bridge Group
Company Information
Company
Ensysce Biosciences
Location
7946 IVANHOE AVE
La Jolla, California, United States
About
Ensysce Biosciences, Inc. (NASDAQ: ENSC) is a clinical-stage biotech company developing a new class of prescription drugs that will provide patients and prescribers safer options for the use of potent prescription drugs, reducing abuse and preventing overdoses.
Fundz sees it the moment Ensysce Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.